[Improving long-term graft survival by limiting nephrotoxicity of immunosuppressors and reducing vascular risk].
Hourmant
M
M
D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D016030:Kidney Transplantation; D011183:Postoperative Complications / Q000139:chemically induced* / Q000517:prevention & control*; D012307:Risk Factors; D013997:Time Factors; D014652:Vascular Diseases / Q000517:prevention & control*
D007166:Immunosuppressive Agents